SO
RIGL icon

STRS Ohio’s Rigel Pharmaceuticals RIGL Stock Holding History

STRS Ohio’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$814K Sell
20,800
-1,900
-8% -$58.6K ﹤0.01% 832
2026
Q1 		$614K Buy
22,700
+7,300
+47% +$245K ﹤0.01% 934
2025
Q4 		$660K Sell
15,400
-2,700
-15% -$102K ﹤0.01% 865
2025
Q3 		$513K Sell
18,100
-10,200
-36% -$305K ﹤0.01% 1082
2025
Q2 		$530K Buy
28,300
+6,700
+31% +$127K ﹤0.01% 1243
2025
Q1 		$389K Sell
21,600
-3,000
-12% -$60.9K ﹤0.01% 1310
2024
Q4 		$414K Hold
24,600
– – ﹤0.01% 1272
2024
Q3 		$398K Buy
24,600
+6,900
+39% +$81.1K ﹤0.01% 1350
2024
Q2 		$145K Hold
17,700
– – ﹤0.01% 1632
2024
Q1 		$261K Hold
17,700
– – ﹤0.01% 1483
2023
Q4 		$256K Hold
17,700
– – ﹤0.01% 1498
2023
Q3 		$191K Hold
17,700
– – ﹤0.01% 1574
2023
Q2 		$228K Buy
17,700
+1,380
+8% +$18.7K ﹤0.01% 1563
2023
Q1 		$215K Hold
16,320
– – ﹤0.01% 1583
2022
Q4 		$244K Hold
16,320
– – ﹤0.01% 1540
2022
Q3 		$192K Hold
16,320
– – ﹤0.01% 1614
2022
Q2 		$184K Buy
16,320
+920
+6% +$18.5K ﹤0.01% 1632
2022
Q1 		$460K Hold
15,400
– – ﹤0.01% 1471
2021
Q4 		$408K Hold
15,400
– – ﹤0.01% 1538
2021
Q3 		$559K Buy
+15,400
New +$606K ﹤0.01% 1465
2016
Q4 		– Sell
-17,570
Closed -$644K – 1982
2016
Q3 		$644K Sell
17,570
-3,560
-17% -$102K ﹤0.01% 1137
2016
Q2 		$471K Buy
21,130
+1,630
+8% +$40.5K ﹤0.01% 1320
2016
Q1 		$405K Hold
19,500
– – ﹤0.01% 1343
2015
Q4 		$590K Buy
19,500
+5,770
+42% +$175K ﹤0.01% 1207
2015
Q3 		$339K Hold
13,730
– – ﹤0.01% 1406
2015
Q2 		$440K Buy
+13,730
New +$524K ﹤0.01% 1364

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

STRS Ohio's RIGL Position: Q2 2026 in Review

STRS Ohio reduced its Rigel Pharmaceuticals (RIGL) stake by 8.4% in Q2 2026, selling an estimated $58.6K and leaving 20,800 shares worth $814K. The position accounts for ﹤0.01% of the portfolio, ranked #832.

STRS Ohio first reported a position in RIGL in Q2 2015 and has held it in 26 quarters since. 156 funds tracked by Wall St. Rank hold RIGL as of Q2 2026.

  • STRS Ohio held 20,800 shares of Rigel Pharmaceuticals worth $814K as of Q2 2026.
  • STRS Ohio sold 1,900 Rigel Pharmaceuticals shares in Q2 2026, an estimated $58.6K.
  • Rigel Pharmaceuticals made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #832 holding.
  • STRS Ohio first reported a position in Rigel Pharmaceuticals in Q2 2015 and has held it in 26 quarters since.
  • 156 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.